share_log

iBio Inc | CORRESP: CORRESP

iBio Inc | CORRESP: CORRESP

iBio Inc | CORRESP:信函
美股SEC公告 ·  2024/04/23 01:12

Moomoo AI 已提取核心信息

iBio Inc, a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on April 16, 2024. The company seeks to have the registration become effective on April 24, 2024, at 4:00 p.m. Eastern Time. This request was communicated in a letter addressed to Jimmy McNamara at the SEC's Division of Corporation Finance. iBio Inc acknowledges its responsibilities under federal securities laws regarding the issuance of securities covered by the Registration Statement. Leslie Marlow of Blank Rome LLP has been authorized by iBio Inc to modify or withdraw the acceleration request if necessary. The SEC has been asked to notify Ms. Marlow once the acceleration has been granted.
iBio Inc, a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on April 16, 2024. The company seeks to have the registration become effective on April 24, 2024, at 4:00 p.m. Eastern Time. This request was communicated in a letter addressed to Jimmy McNamara at the SEC's Division of Corporation Finance. iBio Inc acknowledges its responsibilities under federal securities laws regarding the issuance of securities covered by the Registration Statement. Leslie Marlow of Blank Rome LLP has been authorized by iBio Inc to modify or withdraw the acceleration request if necessary. The SEC has been asked to notify Ms. Marlow once the acceleration has been granted.
生物技术公司iBio Inc已正式要求美国证券交易委员会(SEC)加快其S-3表格注册声明的生效日期,该声明最初于2024年4月16日提交。该公司寻求使注册于美国东部时间2024年4月24日下午4点生效。该请求是在写给美国证券交易委员会公司财务部吉米·麦克纳马拉的一封信中提出的。iBio Inc承认根据联邦证券法,其对注册声明所涵盖证券的发行负有责任。Blank Rome LLP的莱斯利·马洛已获得iBio Inc的授权,可在必要时修改或撤回加速请求。加速批准后,美国证券交易委员会被要求通知马洛女士。
生物技术公司iBio Inc已正式要求美国证券交易委员会(SEC)加快其S-3表格注册声明的生效日期,该声明最初于2024年4月16日提交。该公司寻求使注册于美国东部时间2024年4月24日下午4点生效。该请求是在写给美国证券交易委员会公司财务部吉米·麦克纳马拉的一封信中提出的。iBio Inc承认根据联邦证券法,其对注册声明所涵盖证券的发行负有责任。Blank Rome LLP的莱斯利·马洛已获得iBio Inc的授权,可在必要时修改或撤回加速请求。加速批准后,美国证券交易委员会被要求通知马洛女士。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息